Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Phase III Randomized Double Blind Placebo Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Patients With Small Lung Cancer

NCT00433498 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00433498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00433498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Phase III Randomized Double Blind Placebo Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Patients With Small Lung Cancer
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
November 30, 2013
Enrollment
846 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer